Archived Insight | June 12, 2018

2019 Medicare Part D Drug Benefit Modest Increases from 2018

The Medicare Part D standard defined benefit will be slightly higher in 2019. The Centers for Medicare & Medicaid Services (CMS) provides a Retiree Drug Subsidy (RDS) to sponsors of group health plans that provide prescription drug coverage to Medicare-eligible retirees. The RDS amounts for 2019 will be slightly higher than the 2018 amounts.

This Update features charts comparing the 2019 numbers to the 2018 numbers. It also reviews changes to the Part D benefit, which were made by the Affordable Care Act and the more recent Bipartisan Budget Act of 2018, and illustrates the impact of those changes on the 2019 benefit.

 

2019 Medicare Part D Drug Benefit Modest Increases from 2018

See more insights

Young Couple Going Over Financial Documents At Home

Final Rule on Healthcare Transparency in Coverage

Learn how the Transparency in Coverage final rule affects disclosure requirements, price comparison tools and implementation planning.
Asian Female Pharmacist Uses Computer To Check Inventory For A Drug

Designing and Negotiating Affordable Pharmacy Benefits

Learn how health plan sponsors can improve pharmacy benefit value through PBM contracting, formulary management and clinical oversight.
Man Self Injecting GLP 1 Weight Loss Medication Pen At Home

GLP-1s Have Disrupted the Market for Other Diabetes Drugs

Segal’s SHAPE data shows how rising GLP-1 use coincided with declines in insulin, Metformin and DPP-4 inhibitor use.

This page is for informational purposes only and does not constitute legal, tax or investment advice. You are encouraged to discuss the issues raised here with your legal, tax and other advisors before determining how the issues apply to your specific situations.